Finley M J, Happel C M, Kaminsky D E, Rogers T J
Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Cell Immunol. 2008 Mar-Apr;252(1-2):146-54. doi: 10.1016/j.cellimm.2007.09.008. Epub 2008 Feb 14.
Opioids were originally discovered because of their ability to induce analgesia, but further investigation has shown that the opioids regulate the function of cells involved in the immune response. We suggest that the regulation of cytokine, chemokine, and cytokine receptor expression is a critical component of the immunomodulatory activity of the opioids. In this paper we review the literature dealing with the regulation of cytokine and cytokine receptor expression by agonists for the three major opioid receptor types (mu, kappa, and delta), and nociceptin, the natural agonist for the orphanin FQ/nociceptin receptor. Although the opioid receptors share a high degree of sequence homology, opposing roles between the kappa opioid receptor (KOR) and the mu opioid receptor (MOR) have become apparent. We suggest that activation of the KOR induces an anti-inflammatory response through the down-regulation of cytokine, chemokine and chemokine receptor expression, while activation of the MOR favors a pro-inflammatory response. Investigation into the opioid receptor-like (ORL1)/nociceptin system also suggests a role for this receptor as a down-regulator of immune function. These effects suggest a broad role for opioids in the modulation of the function of the immune system, and suggest possible targets for the development of new therapeutics for inflammatory and infectious diseases.
阿片类药物最初因其诱导镇痛的能力而被发现,但进一步研究表明,阿片类药物可调节参与免疫反应的细胞功能。我们认为,细胞因子、趋化因子和细胞因子受体表达的调节是阿片类药物免疫调节活性的关键组成部分。在本文中,我们综述了有关三种主要阿片受体类型(μ、κ和δ)的激动剂以及孤啡肽/孤啡肽受体的天然激动剂孤啡肽对细胞因子和细胞因子受体表达调节的文献。尽管阿片受体具有高度的序列同源性,但κ阿片受体(KOR)和μ阿片受体(MOR)之间的相反作用已变得明显。我们认为,KOR的激活通过下调细胞因子、趋化因子和趋化因子受体的表达诱导抗炎反应,而MOR的激活则有利于促炎反应。对阿片受体样(ORL1)/孤啡肽系统的研究也表明该受体作为免疫功能下调因子的作用。这些效应表明阿片类药物在调节免疫系统功能方面具有广泛作用,并为开发针对炎症和感染性疾病的新疗法提供了可能的靶点。